Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Aug 26;18(1):20230760.
doi: 10.1515/med-2023-0760. eCollection 2023.

Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery

Affiliations
Review

Aspirin versus LMWH for VTE prophylaxis after orthopedic surgery

Qingqing Wei et al. Open Med (Wars). .

Abstract

Low molecular weight heparin (LMWH) is often used to prevent perioperative venous thrombosis after surgery, but aspirin is also recommended by academics. Studies were searched in electronic databases until February 24, 2023. We performed a meta-analysis to evaluate the safety and efficacy of aspirin and LMWH for venous thromboembolism (VTE) prophylaxis in patients after orthopedic surgery. The outcomes were death from any causes, deep vein thrombosis (DVT), pulmonary embolism (PE), etc. This study was registered with INPLASY, number 202320117. Six randomized controlled trials enrolled 13,851 patients with postoperative joint surgery. The risk of DVT was comparable between the two groups when aspirin was combined with mechanical devices (RR 0.61 [95% CI 0.27-1.39], I² = 62%, P = 0.24). No significant differences in all cause death, PE, wound infection, and wound complication were found between the aspirin and LMWH groups. In this meta-analysis, the mortality rate was comparable between the aspirin and LMWH groups. However, aspirin alone had a higher risk of DVT than LMWH. Based on the results of this meta-analysis, we suggest aspirin combined with mechanical devices for VTE prophylaxis in patients after orthopedic surgery.

Keywords: aspirin; joint surgery; low-molecular-weight heparin; venous thromboembolism.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: Authors state no conflict of interest.

Figures

Figure 1
Figure 1
The flow chart of the search and study selection process.
Figure 2
Figure 2
The outcomes of all cause death.
Figure 3
Figure 3
The outcomes of PE.
Figure 4
Figure 4
The outcomes of wound infection.
Figure 5
Figure 5
The outcomes of DVT.
Figure 6
Figure 6
The outcomes of wound complication.
Figure A1
Figure A1
Risk of bias graph.

Similar articles

References

    1. Knudson MM, Ikossi DG, Khaw L, Morabito D, Speetzen LS. Thromboembolism after trauma: an analysis of 1602 episodes from the American College of Surgeons National Trauma Data Bank. Ann Surg. 2004;240:490–8. 10.1097/01.sla.0000137138.40116.6c. - DOI - PMC - PubMed
    1. Sagi HC, Ahn J, Ciesla D, Collinge C, Molina C, Obremskey WT. Venous thromboembolism prophylaxis in orthopedic trauma patients: a survey of OTAmember practice patterns and OTA expert panel recommendations. J Orthop Trauma. 2015;29(10):e355–62. 10.1097/BOT.0000000000000387. - DOI - PubMed
    1. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuünemann HJ. Executive summary: antithrombotic therapy and prevention of thrombosis, 9th ed. American College of Chest Physicians evidence based clinical practice guidelines. Chest. 2012;141(Suppl):7S–47S. 10.1378/chest.1412S3. - DOI - PMC - PubMed
    1. Drescher FS, Sirovich BE, Lee A, Morrison DH, Chiang WH, Larson RJ. Aspirin versus anticoagulation for prevention of venous thromboembolism major lower extremity orthopedic surgery: a systematic review and meta-analysis. J Hosp Med. 2014;9:579–85. 10.1002/jhm.2224. Epub 2014 Jul 17. - DOI - PubMed
    1. O’Toole RV, Stein DM, O’Hara NN, Frey KP, Taylor TJ, Scharfstein DO, et al. Aspirin or low-molecular-weight heparin for thromboprophylaxis after a fracture. N Engl J Med. 2023;388(3):203–13. 10.1056/NEJMoa2205973. - DOI - PubMed

LinkOut - more resources